Iren [IREN] vs Morgan Stanley [MS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Iren wins in 3 metrics, Morgan Stanley wins in 14 metrics, with 0 ties. Morgan Stanley appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricIrenMorgan StanleyBetter
P/E Ratio (TTM)129.3817.83Morgan Stanley
Price-to-Book Ratio7.172.56Morgan Stanley
Debt-to-Equity Ratio53.05438.54Iren
PEG Ratio148.411.10Morgan Stanley
EV/EBITDA70.03N/AN/A
Profit Margin (TTM)17.35%22.49%Morgan Stanley
Operating Margin (TTM)7.63%34.12%Morgan Stanley
EBITDA Margin (TTM)7.63%34.12%Morgan Stanley
Return on Equity5.97%14.13%Morgan Stanley
Return on Assets (TTM)0.63%1.16%Morgan Stanley
Free Cash Flow (TTM)$-1.13B$-2.10BIren
Dividend YieldN/A2.15%N/A
1-Year Return481.34%46.08%Iren
Price-to-Sales Ratio (TTM)27.393.83Morgan Stanley
Enterprise Value$14.12B$178.59BMorgan Stanley
EV/Revenue Ratio28.192.72Morgan Stanley
Gross Profit Margin (TTM)26.95%N/AN/A
Revenue per Share (TTM)$2$41Morgan Stanley
Earnings per Share (Diluted)$0.39$8.84Morgan Stanley
Beta (Stock Volatility)4.201.32Morgan Stanley
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Iren vs Morgan Stanley Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Iren14.45%20.54%78.87%200.00%735.43%382.41%
Morgan Stanley0.32%-1.57%6.10%9.33%46.01%26.29%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Iren481.34%1,260.11%103.47%103.47%103.47%103.47%
Morgan Stanley46.08%99.66%222.73%381.63%522.39%194.84%

News Based Sentiment: Iren vs Morgan Stanley

Iren

News based Sentiment: POSITIVE

October was a transformative month for IREN, characterized by record stock performance, a major expansion into the AI Cloud with a substantial GPU investment, and a significant earnings beat. These developments, coupled with positive analyst sentiment, strongly suggest a positive shift in the company's trajectory and investment prospects.

View Iren News Sentiment Analysis

Morgan Stanley

News based Sentiment: MIXED

October was a month of strategic positioning for Morgan Stanley, with expansions into cryptocurrency and investments in advisor education. While analyst sentiment is mixed and institutional ownership shows some bearish signals, the firm is proactively adapting to market changes, making it a significant month for investors to watch.

View Morgan Stanley News Sentiment Analysis

Performance & Financial Health Analysis: Iren vs Morgan Stanley

MetricIRENMS
Market Information
Market Cap i$13.72B$251.57B
Market Cap CategoryLarge capMega cap
10 Day Avg. Volume i43,146,6405,110,020
90 Day Avg. Volume i37,400,6635,282,273
Last Close$57.75$158.09
52 Week Range$5.12 - $58.28$94.33 - $163.98
% from 52W High-0.91%-3.59%
All-Time High$58.28 (Oct 06, 2025)$163.98 (Sep 23, 2025)
% from All-Time High-0.91%-3.59%
Growth Metrics
Quarterly Revenue Growth2.23%0.11%
Quarterly Earnings Growth2.21%0.15%
Financial Health
Profit Margin (TTM) i0.17%0.22%
Operating Margin (TTM) i0.08%0.34%
Return on Equity (TTM) i0.06%0.14%
Debt to Equity (MRQ) i53.05438.54
Cash & Liquidity
Book Value per Share (MRQ)$7.04$61.59
Cash per Share (MRQ)$2.08$352.68
Operating Cash Flow (TTM) i$245.89M$-17,670,000,640
Levered Free Cash Flow (TTM) i$-1,121,368,960$12.80B
Dividends
Last 12-Month Dividend Yield iN/A2.15%
Last 12-Month Dividend iN/A$2.79

Valuation & Enterprise Metrics Analysis: Iren vs Morgan Stanley

MetricIRENMS
Price Ratios
P/E Ratio (TTM) i129.3817.83
Forward P/E i148.4119.87
PEG Ratio i148.411.10
Price to Sales (TTM) i27.393.83
Price to Book (MRQ) i7.172.56
Market Capitalization
Market Capitalization i$13.72B$251.57B
Enterprise Value i$14.12B$178.59B
Enterprise Value Metrics
Enterprise to Revenue i28.192.72
Enterprise to EBITDA i70.03N/A
Risk & Other Metrics
Beta i4.201.32
Book Value per Share (MRQ) i$7.04$61.59

Financial Statements Comparison: Iren vs Morgan Stanley

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)IRENMS
Revenue/Sales i$187.29M$16.52B
Cost of Goods Sold i$136.82MN/A
Gross Profit i$50.47MN/A
Research & Development iN/AN/A
Operating Income (EBIT) i$16.81MN/A
EBITDA i$82.81MN/A
Pre-Tax Income i$92.79M$5.54B
Income Tax i$-2.76M$1.17B
Net Income (Profit) i$95.55M$4.37B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)IRENMS
Cash & Equivalents i$564.53M$60.84B
Total Current Assets i$641.17MN/A
Total Current Liabilities i$149.35MN/A
Long-Term Debt i$963.83M$303.93B
Total Shareholders Equity i$1.82B$107.85B
Retained Earnings i$-596.17M$107.65B
Property, Plant & Equipment i$1.46MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)IRENMS
Operating Cash Flow iN/A$-67.29B
Capital Expenditures i$-356.67M$-713.00M
Free Cash Flow i$49.22M$-24.69B
Debt Repayment i$349,000$-20.85B
Common Stock Repurchase iN/A$-2.03B

Short Interest & Institutional Ownership Analysis

MetricIRENMS
Shares Short i30.98M16.22M
Short Ratio i0.963.52
Short % of Float i0.12%0.01%
Average Daily Volume (10 Day) i43,146,6405,110,020
Average Daily Volume (90 Day) i37,400,6635,282,273
Shares Outstanding i258.10M1.61B
Float Shares i241.46M1.21B
% Held by Insiders i0.05%0.24%
% Held by Institutions i0.61%0.63%

Dividend Analysis & Yield Comparison: Iren vs Morgan Stanley

MetricIRENMS
Last 12-Month Dividend iN/A$2.79
Last 12-Month Dividend Yield iN/A2.15%
3-Year Avg Annual Dividend iN/A$3.10
3-Year Avg Dividend Yield iN/A0.90%
3-Year Total Dividends iN/A$9.31
Ex-Dividend DateN/AJan 31, 2025